Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIOP-LGG 2004
2005-005377-29Phase 3Active
- Sponsor
- University Hospital of North Norway
- Start
- Apr 2006
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of etoposide, carboplatin and vincristine in low-grade glioma (LGG), sponsored by University Hospital of North Norway. Primary endpoint: Progression-free survival. Started Apr 2006; status: active.
02
Drugs
etoposidecarboplatinvincristine
03
Conditions
low-grade glioma (LGG)
Beyond the preview
Go deeper on 2005-005377-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005377-29.